C-peptide reverses TGF-β1-induced changes in renal proximal tubular cells: Implications for treatment of diabetic nephropathy

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 3, 2009, Pages

  Hills, Claire E ^a   Al Rasheed, Nawal ^b   Al Rasheed, Nouf ^b   Willars, Gary B ^a   Brunskill, Nigel J ^a,c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Tubulointerstitial fibrosis

Indexed keywords

C PEPTIDE; GLUCOSE; LUCIFERASE; PERTUSSIS TOXIN; PHALLOIDIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN;

ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; DIABETIC NEPHROPATHY; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

BIOLOGICAL MARKERS; C-PEPTIDE; CADHERINS; CELL LINE; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; HUMANS; KIDNEY TUBULES, PROXIMAL; MESODERM; PHENOTYPE; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; VIMENTIN;

EID: 66049134863     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90500.2008     Document Type: Article

References (54)

1. Al-Rasheed NM, Meakin F, Royal EL, Lewington AJ, Brown J, Willars GB, Brunskill NJ. Potent activation of multiple signalling pathways by C peptide in opossum kidney proximal tubular cells. Diabetologia 47: 987-997, 2004. (Pubitemid 38918157)
2. Al-Rasheed NM, Chana RS, Baines RJ, Willars GB, Brunskill NJ. Ligand-independent activation of peroxisome proliferator-activated receptor- gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity. J Biol Chem 279: 49747-49754, 2004.
3. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275: 36803-36810, 2000.
4. Bland R, Walker EA, Hughes SV, Stewart PM, Hewison M. Constitutive expression of 25-hydroxyvitamin D3-1α-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium. Endocrinology 140: 2027-2034, 1999. (Pubitemid 30636439)
5. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, Thomas MC, Cooper ME, Kantharidis P. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 7: 2484-2494, 2006. (Pubitemid 44300964)
6. Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Ren Fail 23: 471-481, 2001. (Pubitemid 32692282)
7. Cohen MP, Sharma K, Guo J, Eltayeb BO, Ziyadeh FN. The renal TGF-β system in the db/db mouse model of diabetic nephropathy. Exp Nephrol 6: 226-233, 1998. (Pubitemid 28247581)
8. De Caestecker MP, Piek E, Roberts AB. Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst 92: 1388-1402, 2000.
9. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor. EMBO J 17: 3091-3100, 1998.
10. Di Paolo S, Gesualdo L, Ranieri E, Grandaliano G, Schena FP. High glucose concentration induces overexpression of a transforming growth factor-β through the activation of a platelet derived growth factor loop in human mesangial cells. Am J Pathol 149: 2095-2106, 1996. (Pubitemid 26415226)
11. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 12: 2495-2508, 1996.
12. Felici A, Wurthner JU, Parks WT, Giam LRY, Reiss M, Karpova TS. TLP: a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling. EMBO J 22: 4465-4477, 2003. (Pubitemid 37087200)
13. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 85: 47-64, 2004.
14. Fraser D, Brunskill N, Ito T, Phillips A. Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-beta 1 synthesis via an autocrine PDGF loop. Am J Pathol 63: 2565-2574, 2003. (Pubitemid 37466497)
15. Hills CE, Bland R, Wheelans DC, Bennett J, Ronco PM, Squires PE. Glucose evoked alterations in connexin-43-mediated cell-to-cell communication in human collecting duct: a possible role in diabetic nephropathy. Am J Physiol Renal Physiol 291: F1045-F1051, 2006.
16. Hills CE, Bland R, Bennett J, Ronco PM, Squires PE. High glucose upregulates ENaC and SGK1 expression in HCD-cells. Cell Physiol Biochem 18: 337-346, 2006.
17. Huang DY, Richter K, Breidenbach A, Vallon V. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose response study. Naunyn Schmiedebergs Arch Pharmacol 365: 67-73, 2002. (Pubitemid 34045241)
18. Humes HD, Nakamura T, Cieslinski DA, Miller D, Emmons RV, Border WA. Role of proteoglycans and cytoskeleton in the effects of TGF-beta 1 on renal proximal tubule cells. Kidney Int 43: 575-584, 1993. (Pubitemid 23071940)
19. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002.
20. Ju W, Ogawa A, Heyer J, Nierhof D, Yu L, Kucherlapati R, Shafritz DA, Bottinger EP. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 26: 654-667, 2006. (Pubitemid 43089776)
21. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784, 2003. (Pubitemid 38063698)
22. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 233: 4-11, 2008.
23. Lindschau C, Quass P, Menne J, Güler F, Fiebeler A, Leitges M, Luft FC, Haller H. Glucose-induced TGF-beta1 and TGF-beta receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-alpha. Hypertension 42: 335-341, 2003. (Pubitemid 37093482)
24. Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y. Influence of C-peptide on early glomerular changes in diabetic mice. Diabetes Metab Res Rev 22: 313-322, 2006. (Pubitemid 44070508)
25. Masszi A, Fan L, Rosivall L, McCulloch CA, Rotstein OD, Mucsi I, Kapus A. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol 165: 1955-1967, 2004. (Pubitemid 39578374)
26. Okada H, Danoff TM, Kalluri R, Neilson EG. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol Renal Physiol 273: F563-F574, 1997. (Pubitemid 27479736)
27. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108: 1853-1863, 2001.
28. Patel S, Mason RM, Suzuki J, Imaizumi A, Kamimura T, Zhang Z. Inhibitory effect of statins on renal epithelial-to-mesenchymal transition. Am J Nephrol 26: 381-387, 2006. (Pubitemid 44394157)
29. Phanish MK, Wahab NA, Colville-Nash P, Hendry BM, Dockrell ME. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells Biochem J 15: 601-607, 2006.
30. Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 12: 4557-4668, 1999.
31. Pollack V, Sarközi R, Banki Z, Feifel E, Wehn S, Gstraunthaler G, Stoiber H, Mayer G, Montesano R, Strutz F, Schramek H. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling. Am J Physiol Renal Physiol 293: F1714-F1726, 2007. (Pubitemid 350086008)
32. Qi W, Chen X, Zhang Y, Waltham M, Schache M, Kelly DJ, Pollock CA. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism. Nephrol Dial Transplant 11: 3147-3153, 2007. (Pubitemid 350202549)
33. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Müller GA, Colasanti G, D'Amico G. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62: 137-146, 2002. (Pubitemid 34754056)
34. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 51: 2-15, 1997. (Pubitemid 27064516)
35. Rigler R, Pramanik A, Jonasson P. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 96: 13318-13323, 1999.
36. Ritz E, Tarng DC. Renal disease in type 2 diabetes. Nephrol Dialysis Transplant 16: 11-18, 2001. (Pubitemid 32750424)
37. Roberts AB. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24: 111-119, 1998.
38. Rubenstein AH, Melani F, Pilkis S, Steiner DF. Proinsulin: Secretion, metabolism, immunological and biological properties. Postgrad Med J 45 Suppl: 476-481, 1969.
39. Samnegård B, Jacobson S, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 60: 1258-1265, 2001. (Pubitemid 32960021)
40. Samnegård B, Jacobson S, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjoquist M. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 20: 532-538, 2005. (Pubitemid 40378421)
41. Scalia R, Coyle K, Levine B, Booth G, Lefer A. C peptide inhibits leukocyte-endothelium interaction in the microcirculation during endothelial dysfunction. FASEB J 14: 2357-2364, 2000.
42. Sharma K, Ziyadeh FN. Hyperglycaemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44: 1139-1146, 1995.
43. Sjoquist M, Huang W, Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 54: 758-764, 1998. (Pubitemid 28397393)
44. Tian YC, Fraser D, Attisano L, Philips AO. TGF-β1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol Renal Physiol 285: F130-F142, 2003. (Pubitemid 36818470)
45. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746, 2003.
46. Van Ibberghen-Schilling E, Roche NS, Flanders KC, SpornMB, Roberts AB. Transforming growth factor β-1 positively regulates its own expression in normal and transformed cells. J Biol Chem 263: 7741-7746, 1988.
47. Vogelmann R, Nguyen-Tat MD, Giehl K, Adler G, Wedliach D, Menke A. TGF-beta-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN. J Cell Sci 118: 4901-4912, 2005. (Pubitemid 41646396)
48. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, Rigler R, Jörnvall H. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 278: E759-E768, 2000. (Pubitemid 30366391)
49. Wahren J. C-peptide: new findings and therapeutic implications in diabetes. Clin Physiol Funct Imaging 24: 180-189, 2004. (Pubitemid 39089034)
50. Wallerath T, Kunt T, Forst T, Closs EI, Lehmann R, Flohr T, Gabriel M, Schäfer D, Göpfert A, Pfützner A, Beyer J, Förstermann U. Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 9: 95-102, 2003. (Pubitemid 37386378)
51. White KE, Marshall SM, Bilous RW. Are glomerular volume differences between type 1 and type 2 diabetic patients pathologically significant? Diabetologia 50: 906-912, 2009.
52. Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 82: 175-181, 2004. (Pubitemid 38392167)
53. Ziyadeh FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22: 736-744, 1993.
54. Ziyadeh FN. Mediators of diabetic renal disease: the case for TGF-beta as the major mediator. J Am Soc Nephrol 15: S55-S57, 2004.